Results 171 to 180 of about 26,042 (243)

Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol. [PDF]

Medicine (Baltimore), 2021
Hirai I, Tanese K, Fukuda K, Fusumae T, Nakamura Y, Sato Y, Amagai M, Funakoshi T.   +7 more
europepmc   +1 more source

Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase. [PDF]

J Cancer Res Clin Oncol
Zhang J, Zhou S, Jiang S, He F, Tu Y, Hu H.   +5 more
europepmc   +1 more source

The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate. [PDF]

F1000Res, 2021
Wardhani SO, Susianti H, Rahayu P, Yueniwati YP, Fajar JK.   +4 more
europepmc   +1 more source

O tratamento da Leucemia Mielóide Crônica com mesilato de imatinibe Therapy of Chronic Myeloid Leukemia with imatinib mesylate

, 2008
Vaneuza M. Funke, D.C. Setubal, Jefferson Ruiz, Ana Paula de Azambuja, Denise H. Lima, Terezinha K. Kojo, Ricardo Pasqüini   +6 more
openalex   +1 more source

Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin [PDF]

, 2020
Hélio A.G. Teive, Francisco Manoel Branco Germiniani, Renato P. Munhoz, Carlos Henrique Ferreira Camargo   +3 more
openalex   +1 more source

Imatinib Mesylate [PDF]

, 2020
openaire   +1 more source

Imatinib Mesylate Causes Potential Cardiac Dysfunction in Patients With Chronic Myeloid Leukemia: the Results of a Case-control Study. [PDF]

Indian J Hematol Blood Transfus
Shankar G, Jain A, Gupta A, Jandial A, Varma N, Jain A, Prakash G, Khadwal A, Malhotra P.   +8 more
europepmc   +1 more source

Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate. [PDF]

Front Oncol, 2022
Siti Mariam I, Norhidayah R, Zulaikha AB, Nazihah MY, Rosline H, Kausar GA, Sarina S, Azlan H, Ankathil R.   +8 more
europepmc   +1 more source

One Case of Imatinib Mesylate-Associated Diarrhea Successfully Treated with HANGESHASHINTO

, 2008
Atsushi CHINO, Nobuyasu SEKIYA, Kenji Ohno, Yoshiro HIRASAKI, Katsumi Hayashi, Yuji KASAHARA, Toshiaki KITA, Takao Namiki, Katsutoshi TERASAWA   +8 more
openalex   +2 more sources

QbD-based co-loading of paclitaxel and imatinib mesylate by protamine-coated PLGA nanoparticles effective on breast cancer cells. [PDF]

Nanomedicine (Lond)
Laxane N, Yadav KS.
europepmc   +1 more source